Targeting oxygenases could be a viable anti-metastatic approach in cancer therapy

Pengfei Shi1, Jie Xu1, Hongjuan Cui1

  • 1Jinfeng Laboratory, 401329 Chongqing, China; Cancer Center, Medical Research Institute, Southwest University, 400716 Chongqing, China.

Insights

Oxygenases are key enzymes in cancer metastasis. Targeting these enzymes with drugs shows promise for inhibiting cancer spread and improving patient outcomes.

Area of Science:

  • Oncology
  • Biochemistry
  • Molecular Biology

Background:

  • Malignant tumors exhibit uncontrolled growth, invasion, and metastasis, leading to over 90% of cancer deaths.
  • Cancer cell metastasis involves significant metabolic alterations, with enzymes mediating synthesis and degradation.
  • Oxygenases, oxidative enzymes, are increasingly recognized for their role in cancer progression.

Purpose of the Study:

  • To summarize the mechanisms by which oxygenases influence cancer cell behavior.
  • To review preclinical and clinical studies on targeted therapies involving oxygenases for cancer metastasis.

Main Methods:

  • Review of scientific literature on oxygenases and cancer metastasis.
  • Analysis of genomic and proteomic data revealing oxygenase expression in metastatic tumors.
  • Examination of studies on oxygenase-targeted drugs in preclinical and clinical settings.

Main Results:

  • Oxygenases are highly expressed in metastatic tumor cells, enhancing proteins that drive metastasis.
  • Targeting oxygenases with specific drugs can inhibit tumor metastasis.
  • Several oxygenase-targeting agents are currently in clinical evaluation.

Conclusions:

  • Oxygenases play a critical role in regulating cancer cell behavior and metastasis.
  • Targeted inhibition of oxygenases represents a promising therapeutic strategy for combating cancer metastasis.
  • Further research and clinical trials are essential to fully realize the potential of oxygenase-targeted therapies.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.4K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
9.6K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.5K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.4K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K